September 2019 CHR VOICE Digest
How quickly time passes, especially during the summer months! It seems only like yesterday that we wished all of our readers a wonderful vacation season and announced our usual summer break in publishing this newsletter for the months of July and August. As we are writing this introduction to our September VOICE, the end of summer is upon us and, before we know it, we will be speeding toward the year-end holiday season. One reason why here at CHR the summer months passed so quickly this year was that they were unusually busy clinically. We, therefore, also expect a busier fall season than usual. With summer vacations over, we are back to full manpower, and are looking forward to the challenges.
When it comes to medically relevant news, the summer months this year were surprisingly quiet. Only one subject that made headlines over the summer got our writers’ fingers a bit itchy but, ultimately, was not considered worth interrupting the VOICE’s summer hiatus; and that was the disturbing story that some fertility centers, through direct-to-public genetic testing, were found to have used their own physicians’ semen in place of semen from sperm donor agencies, as had been represented to patients. We are addressing this subject in this newsletter, together with another development that caught the attention of the media: colleagues down the street at Weill-Cornell starting to experiment with genetic editing of sperm that carries abnormal mutations using CRISPR/Cas-9. As always, we also address issues our readers raised, such as causes and prevention of early miscarriages (our lead article), the so-called lymphocyte immunization to prevent miscarriages and a new treatment developed at CHR, which we've termed "rebound."
In this issue of the CHR VOICE, we cover:
- [Causes of early miscarriages at 6-8 weeks](https://www.centerforhumanreprod.com/fertility/causes-of-early-miscarriages-at-6-8-weeks/(opens in a new tab))
- Early miscarriage risk factors and testing for early miscarriage risks
- Preventing early miscarriages at 6-8 weeks
- Reproductive endocrinologists as sperm donors
- Lympcyte immunization therapy to prevent miscarriages?
- Gene editing of sperm via CRISPR/Cas-9
- "Rebound" effect after poor response to IVF medications
- CHR in the media
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over 17,800 babies into the world.Discover your treatment options
- Breaking News in ScienceLetter to President Biden and Secretary Designate of HHS, Xavier Becerra In a published letter (Santoro et al Reprod Sciences 2021; https:/doi.org/10.1007/s43032-021-00491-9), a
- More On COVID-19DOES THE BRITISH STRAIN B.1.1.7 INCREASE MORTALITY OVER D614G? A just published study by British investigators claims that not only infectivity of the
- Mild Ovarian StimulationTwo prominent voices in the fertility field known as longstanding supporters of mild ovarian stimulation were at it once again (Nargund and Fauser, Reprod Biomed Online 2020;41:569-571) when
- Brief Case Studies in Clinical InfertilityIs there a place for DHEA and CoQ10 in women undergoing “planned” egg-freezing? At CHR, women undergoing egg-freeing cycles undergo a very